The Relationship Between HIV Pre-exposure Prophylaxis Stigma and Treatment Adherence Among Current HIV Pre-exposure Prophylaxis Users in the Southeastern US

被引:4
作者
Van Gerwen, Olivia T. [1 ]
Yigit, Ibrahim [2 ]
Crockett, Kaylee B. [3 ]
Turan, Bulent [4 ,5 ]
机构
[1] Univ Alabama Birmingham, Div Infect Dis, 703 19th St South,ZRB 218A, Birmingham, AL 35233 USA
[2] TED Univ, Fac Arts & Sci, Dept Psychol, Ankara, Turkey
[3] Univ Alabama Birmingham, Dept Family & Community Med, Birmingham, AL USA
[4] Koc Univ, Coll Social Sci & Humanities, Dept Psychol, Istanbul, Turkey
[5] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
HIV pre-exposure prophylaxis; Adherence; Stigma; PrEP; TENOFOVIR DISOPROXIL FUMARATE; INTERNALIZED STIGMA; PREVENTION; MECHANISMS; INFECTION; EFFICACY; PEOPLE; SCALE; RISK; PREP;
D O I
10.1007/s10461-022-03883-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Despite efficacy in HIV prevention, Pre-exposure Prophylaxis (PrEP) is underutilized in the US, especially among populations at highest risk. PrEP-related stigma may play a role. We developed measures of PrEP-related stigma dimensions and PrEP adherence. We administered them to current PrEP users. We hypothesized that PrEP-related stigma would negatively impact PrEP adherence. Questionnaire measures were developed using data from previous qualitative work and existing validated HIV-related stigma measures. The resultant survey was administered to current PrEP users from two Birmingham, Alabama PrEP clinics. Plasma tenofovir disoproxil fumarate levels were collected to measure PrEP adherence. Exploratory factor analyses were performed to determine the factor structure of each PrEP-related stigma dimension (internalized, perceived, experienced, anticipated, disclosure concerns). Separate binary logistic (or linear) regressions were performed to assess associations between PrEP-related stigma dimensions and adherence (treatment adherence self-efficacy, self-reported adherence, and plasma tenofovir levels), adjusting for education, race, and time on PrEP. In 2018, 100 participants completed the survey, with 91 identifying as male and 66 as white. Only internalized stigma was associated with lower self-reported PrEP adherence. Exploratory mediation analyses suggested that the association between all stigma dimensions and self-reported PrEP adherence is mediated by PrEP adherence self-efficacy. No associations were found between any PrEP-related stigma measures and plasma tenofovir levels. Internalized PrEP stigma may reduce PrEP adherence, possibly by reducing PrEP adherence self-efficacy among experienced PrEP users. Further investigation of how stigma dimensions affect PrEP adherence in populations at risk for HIV may shed light on drivers of PrEP underutilization.
引用
收藏
页码:1478 / 1485
页数:8
相关论文
共 50 条
  • [41] The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis
    Farmer, Eric K.
    Koren, David E.
    Cha, Agnes
    Grossman, Katlyn
    Cates, Drew W.
    AIDS PATIENT CARE AND STDS, 2019, 33 (05) : 207 - 213
  • [42] Pre-exposure prophylaxis adherence and discontinuation at an urban pre-exposure prophylaxis program in Atlanta, Georgia
    Yacout, Hiba
    Smith, Bradley L.
    Foster, Shelbie
    Lora, Meredith
    Niles-Carnes, Larisa V.
    Zheng, Ziduo
    Kundu, Suprateek
    Cantos, Valeria D.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2023, 6 (06): : 576 - 580
  • [43] Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting
    Montgomery, Madeline C.
    Oldenburg, Catherine E.
    Nunn, Amy S.
    Mena, Leandro
    Anderson, Peter
    Liegler, Teri
    Mayer, Kenneth H.
    Patel, Rupa
    Almonte, Alexi
    Chan, Philip A.
    PLOS ONE, 2016, 11 (06):
  • [44] Pre-exposure prophylaxis use among HIV serodiscordant couples: a qualitative study in Mozambique
    Sack, Daniel E.
    De Schacht, Caroline
    Paulo, Paula
    Graves, Erin
    Emilio, Almiro M.
    Matino, Ariano
    Fonseca, Carlota L.
    Aboobacar, Arifo U.
    Van Rompaey, Sara
    Audet, Carolyn M.
    GLOBAL HEALTH ACTION, 2021, 14 (01)
  • [45] Knowledge and perception of HIV pre-exposure prophylaxis among healthcare workers
    Gil, Paula Knoch Mendonca
    Conrado, Danilo dos Santos
    do Nascimento, Ana Isabel
    da Cunha, Joao Cesar Pereira
    Koch, Gabriel Serrano Ramires
    Maciel, Camila Guadeluppe
    Santos-Pinto, Claudia Du Bocage
    de Oliveira, Everton Falcao
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2025, 37 (05): : 780 - 789
  • [46] HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review
    de Carvalho, Nathalia Pacifico
    Pinto Mendicino, Cassia Cristina
    Fonseca Candido, Raissa Carolina
    Dutra Alecrim, Denyr Jeferson
    Menezes de Padua, Cristiane Aparecida
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2019, 31 (10): : 1234 - 1240
  • [47] HIV Pre-Exposure Prophylaxis for Conception Among HIV Serodiscordant Couples in the United States: A Cohort Study
    Leech, Ashley A.
    Biancarelli, Dea
    Aaron, Erika
    Miller, Emily S.
    Coleman, Jenell S.
    Anderson, Peter L.
    Nkwihoreze, Hervette
    Condron, Brianne
    Sullivan, Meg
    AIDS PATIENT CARE AND STDS, 2020, 34 (07) : 295 - 302
  • [48] Primary HIV-1 infection in users of pre-exposure prophylaxis
    Ambrosioni, Juan
    Petit, Elisa
    Liegeon, Geoffroy
    Laguno, Montserrat
    Miro, Jose M.
    LANCET HIV, 2021, 8 (03): : e166 - e174
  • [49] HIV Antiretroviral Treatment and Pre-exposure Prophylaxis in Transgender Individuals
    Poteat, Tonia C.
    Radix, Asa
    DRUGS, 2020, 80 (10) : 965 - 972
  • [50] HIV Pre-exposure Prophylaxis Persistence and Adherence Among Men Who Have Sex With Men in Four US Cities
    Chapin-Bardales, Johanna
    Haaland, Richard
    Martin, Amy
    Holder, Angela A.
    Butts, Virginia
    Sionean, Catlainn
    Sey, Ekow Kwa A.
    Brady, Kathleen F.
    Raymond, Henry
    Opoku, Jenevieve
    Kuo, Irene
    Paz-Bailey, Gabriela
    Wejnert, Cyprian
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2023, 93 (01) : 34 - 41